5 Minutes Read

COVID-19: India logs 1,226 cases of JN.1 variant, highest from Karnataka, Andhra Pradesh

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

 Listen to the Article (6 Minutes)

Summary

The Centre has asked the states and Union Territories to maintain a constant vigil amid an uptick in the number of Covid cases and the detection of the JN.1 sub-variant in the country.

A total of 1,226 cases of COVID-19 sub-variant JN.1 have been reported in the country so far with Karnataka and Andhra Pradesh recording the highest number of cases till now, according to INSACOG on Thursday.Da ta compiled by the Indian SARS-CoV-2 Genomics Consortium (INSACOG) showed that 17 states and UTs have detected the presence of the variant.

Karnataka has detected 234 cases of JN.1 sub-variant followed by Andhra Pradesh (189), Maharashtra (170), Kerala (156), West Bengal (96), Goa (90), Tamil Nadu (88) and Gujarat (76). Rajasthan recorded 37 JN.1 cases, Telangana 32, Chhattisgarh 25, Delhi 16, Uttar Pradesh 7, Haryana five, Odisha three, and Uttarakhand and Nagaland one each, according to the data accessed by PTI.

The Centre has asked the states and Union Territories to maintain a constant vigil amid an uptick in the number of Covid cases and the detection of the JN.1 sub-variant in the country.

The states have been urged to ensure effective compliance with the detailed operational guidelines for the revised surveillance strategy for COVID-19 shared with them by the Union Ministry of Health and Family Welfare. The states have also been asked to regularly monitor and report district-wise cases of influenza-like illness (ILI) and severe acute respiratory illness (SARI) from all health facilities for early detection of a rising trend of Covid cases.

The World Health Organisation has classified JN.1 as a separate “variant of interest” (VOI) given its rapidly increasing spread but said it poses “low” global public health risk.

The JN.1 sub-variant of the coronavirus was previously classified as a VOI as part of the BA.2.86 sub-lineages, the parent lineage that is classified as a VOI, the world body said.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

 Daily Newsletter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Previous Article

Oil Fluctuates as Traders Assess China’s Vow, Unrest in Libya

Next Article

Shanghai residents turn to NFTs to record COVID lockdown, combat censorship

LIVE TV

today's market

index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95

Currency

Company Price Chng %Chng
Dollar-Rupee 73.3500 0.0000 0.00
Euro-Rupee 89.0980 0.0100 0.01
Pound-Rupee 103.6360 -0.0750 -0.07
Rupee-100 Yen 0.6734 -0.0003 -0.05
Quiz
Powered by
Are you a Crypto Head? It’s time to prove it!
10 Questions · 5 Minutes
Start Quiz Now
Win WRX (WazirX token) worth Rs. 1500.
Question 1 of 5

What coins do you think will be valuable over next 3 years?

Answer Anonymously

Should Elon Musk be able to buy Twitter?

 5 Minutes Read

COVID-19: India reports 682 cases of JN.1 from 12 states till Jan 7

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

 Listen to the Article (6 Minutes)

Summary

The WHO has classified JN.1 as a separate “variant of interest” given its rapidly increasing spread but said it poses a “low” global public health risk.

The number of cases of COVID-19 sub-variant JN.1 reported from 12 states till January 7 rose to 682, official sources said on Monday. They said 199 cases have been reported from Karnataka, 148 from Kerala, 139 from Maharashtra, 47 from Goa, 36 from Gujarat, 30 from Andhra Pradesh, 30 from Rajasthan, 26 from Tamil Nadu, 21 from Delhi, three from Odisha, two from Telangana and one from Haryana.

Even though the number of cases is rising and the JN.1 sub-variant has been detected in the country, there is no cause of immediate concern as the majority of those infected are opting for home-based treatment, indicating mild illness, officials said. The Centre has asked the states and Union territories to maintain a constant vigil amid an uptick in the number of Covid cases and the detection of the JN.1 sub-variant in the country.

States have been urged to ensure effective compliance with the detailed operational guidelines for revised surveillance strategy for COVID-19 shared by the Union Ministry of Health and Family Welfare. They have asked to monitor and report district-wise cases of influenza-like illness and severe acute respiratory illness in all health facilities regularly for early detection of rising trend of cases.

The WHO has classified JN.1 as a separate “variant of interest” given its rapidly increasing spread but said it poses a “low” global public health risk. The JN.1 sub-variant of the coronavirus was previously classified as a variant of interest (VOI) as part of the BA.2.86 sub-lineages, the parent lineage that is classified as a VOI, the world body said.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

 Daily Newsletter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Previous Article

Oil Fluctuates as Traders Assess China’s Vow, Unrest in Libya

Next Article

Shanghai residents turn to NFTs to record COVID lockdown, combat censorship

LIVE TV

today's market

index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95

Currency

Company Price Chng %Chng
Dollar-Rupee 73.3500 0.0000 0.00
Euro-Rupee 89.0980 0.0100 0.01
Pound-Rupee 103.6360 -0.0750 -0.07
Rupee-100 Yen 0.6734 -0.0003 -0.05
Quiz
Powered by
Are you a Crypto Head? It’s time to prove it!
10 Questions · 5 Minutes
Start Quiz Now
Win WRX (WazirX token) worth Rs. 1500.
Question 1 of 5

What coins do you think will be valuable over next 3 years?

Answer Anonymously

Should Elon Musk be able to buy Twitter?

 5 Minutes Read

54% of families in Karnataka have at least one member with COVID, viral symptoms, survey shows

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

 Listen to the Article (6 Minutes)

Summary

Out of 3,783 responses, 23% indicated that ‘four or more individuals’ in their household have one or more Covid/ viral fever symptoms; 23% said ‘two-three members’; 8% hinted at one person, and 46% stated no one

Karnataka, which has been grappling with Covid, has at least 54% of households having one or more persons unwell with viral or flu-like symptoms, a survey by LocalCircles shows.

Respondents were asked about the number of people in their family who currently have one or more Covid/flu/viral fever symptoms such as runny nose, sore throat, cough, headache, joint pain, body ache, respiratory issues. Out of 3,783 responses, 23% indicated that “four or more individuals” in their household have one or more Covid/viral fever symptoms; 23% said “two-three members”; 8% hinted at one person, and 46% stated no one.

In August, a similar survey was conducted in Karnataka, in which 33% of households were found to have one or more individuals down with Covid or viral symptoms compared to 54% this time around.

A few weeks ago, the Union Health Ministry sent an advisory to local authorities to maintain surveillance of “trends of influenza like illness (ILI) and severe acute respiratory infections (SARI)” leading to the state government stepping up vigilance. The states were asked to monitor “increase in respiratory illness predominantly due to usual causes like influenza, mycoplasma pneumonia, SARSCoV-2”. In addition, the states were asked to review hospital preparedness in terms of the availability of beds, masks, oxygen cylinders, antibiotics and ventilators.

A total of 15 deaths have been reported in the state since December 15, out of which, three patients were infected with JN.1 sub-variant.

Health officials said most of the Covid deaths in Karnataka were due to presence of comorbidities. Experts have stressed that there is no need to panic in the state as the infectious JN.1 variant seems to be affecting those who are elderly or have comorbidities.

With the majority of individuals with viral or Covid-like symptoms not undertaking the RT-PCR test, LocalCircles decided to conduct a citizen survey in Karnataka to estimate the magnitude of illnesses.

The LocalCircles survey received over 3,000 responses from residents of Karnataka. 62% respondents were men while 38% respondents were women.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

 Daily Newsletter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Previous Article

Oil Fluctuates as Traders Assess China’s Vow, Unrest in Libya

Next Article

Shanghai residents turn to NFTs to record COVID lockdown, combat censorship

LIVE TV

today's market

index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95

Currency

Company Price Chng %Chng
Dollar-Rupee 73.3500 0.0000 0.00
Euro-Rupee 89.0980 0.0100 0.01
Pound-Rupee 103.6360 -0.0750 -0.07
Rupee-100 Yen 0.6734 -0.0003 -0.05
Quiz
Powered by
Are you a Crypto Head? It’s time to prove it!
10 Questions · 5 Minutes
Start Quiz Now
Win WRX (WazirX token) worth Rs. 1500.
Question 1 of 5

What coins do you think will be valuable over next 3 years?

Answer Anonymously

Should Elon Musk be able to buy Twitter?

 5 Minutes Read

India reports 511 cases of JN.1 variant of COVID-19 till Jan 2

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

 Listen to the Article (6 Minutes)

Summary

The INSACOG’s data showed 279 Covid cases recorded in the country in December had the presence of JN.1, while 33 such cases were detected in November 2023.

India has reported 511 cases of JN.1 variant of COVID-19 till January 2. Eleven states have so far detected the presence of the JN.1 sub-variant of the virus.

Karnataka has reported the highest number of cases at 199 followed by Kerala (148), Goa (47). Gujarat has added 36 cases, Maharashtra (32), Tamil Nadu (26), Delhi (15), Rajasthan (4), Telangana (2) and one each from Odisha and Haryana, according to the data by the Indian SARS-CoV-2 Genomics Consortium (INSACOG).

The INSACOG’s data showed 279 Covid cases recorded in the country in December had the presence of JN.1, while 33 such cases were detected in November 2023.

The World Health Organisation (WHO) has classified JN.1 as a separate “variant of interest” given its rapidly-increasing spread, but said it poses a “low” global public health risk. The JN.1 sub-variant of the coronavirus was previously classified as a variant of interest (VOI) as part of the BA.2.86 sub-lineages, the parent lineage that is classified as a VOI, the world body said.

However, in recent weeks, JN.1 cases continued to be reported from multiple countries and its prevalence has rapidly increased globally. The Centre has asked states and Union territories to maintain a constant vigil amid an uptick in the number of Covid cases and the detection of the JN.1 sub-variant in the country.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

 Daily Newsletter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Previous Article

Oil Fluctuates as Traders Assess China’s Vow, Unrest in Libya

Next Article

Shanghai residents turn to NFTs to record COVID lockdown, combat censorship

LIVE TV

today's market

index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95

Currency

Company Price Chng %Chng
Dollar-Rupee 73.3500 0.0000 0.00
Euro-Rupee 89.0980 0.0100 0.01
Pound-Rupee 103.6360 -0.0750 -0.07
Rupee-100 Yen 0.6734 -0.0003 -0.05
Quiz
Powered by
Are you a Crypto Head? It’s time to prove it!
10 Questions · 5 Minutes
Start Quiz Now
Win WRX (WazirX token) worth Rs. 1500.
Question 1 of 5

What coins do you think will be valuable over next 3 years?

Answer Anonymously

Should Elon Musk be able to buy Twitter?

 5 Minutes Read

COVID-19: India records 628 fresh cases, active caseload at 4,054

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

 Listen to the Article (6 Minutes)

Summary

The country’s Covid case tally is currently at 4,50,09,248 (4.50 crore). The total fatalities were recorded at 5,33,334 (5.33 lakh) with one new death reported from Kerala in the previous 24 hours, the data updated at 8 am showed.

India recorded a single-day rise of 628 new COVID-19 cases while the active caseload jumped to 4,054, according to Union Health Ministry data.

The total fatalities were recorded at 5,33,334 (5.33 lakh) with one new death reported from Kerala in the previous 24 hours, the data updated at 8 am showed.

The country’s Covid case tally is currently at 4,50,09,248 (4.50 crore).

The number of people who have recuperated from the disease has risen to 4,44,71,860 (4.44 crore) while the national recovery rate stands at 98.81%, according to the health ministry website.

The case fatality rate stands at 1.19%.

According to the ministry website, 220.67 crore Covid vaccine doses have been administered.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

 Daily Newsletter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Previous Article

Oil Fluctuates as Traders Assess China’s Vow, Unrest in Libya

Next Article

Shanghai residents turn to NFTs to record COVID lockdown, combat censorship

LIVE TV

today's market

index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95

Currency

Company Price Chng %Chng
Dollar-Rupee 73.3500 0.0000 0.00
Euro-Rupee 89.0980 0.0100 0.01
Pound-Rupee 103.6360 -0.0750 -0.07
Rupee-100 Yen 0.6734 -0.0003 -0.05
Quiz
Powered by
Are you a Crypto Head? It’s time to prove it!
10 Questions · 5 Minutes
Start Quiz Now
Win WRX (WazirX token) worth Rs. 1500.
Question 1 of 5

What coins do you think will be valuable over next 3 years?

Answer Anonymously

Should Elon Musk be able to buy Twitter?

 5 Minutes Read

India reports 63 cases of subvariant JN.1, health officials monitoring situation

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

 Listen to the Article (6 Minutes)

Summary

Even though the number of cases is rising and the JN.1 sub-variant has been detected in the country, there is no cause of immediate concern as 92% of those infected are opting for home-based treatment, indicating a mild illness, officials had said.

A total of 63 cases of COVID-19 sub-variant JN.1 have been reported in India till Sunday, December 24, official sources said on Monday. This includes 34 cases from Goa, nine cases from Maharashtra, eight cases from Karnataka and six from Kerala, four from Tamil Nadu and two from Telangana, they added.

According to Union Health Ministry data, the country recorded a single-day rise of 628 new COVID-19 cases while the active caseload jumped to 4,054. The total fatalities were recorded at 5,33,334 (5.33 lakh) with one new death reported from Kerala in the previous 24 hours, the data updated at 8 am showed.

NITI Aayog member (Health) Dr V K Paul said last week that the scientific community in India is closely investigating the new Covid sub-variant and stressed the need for states to ramp up testing and strengthen their surveillance systems.

Even though the number of cases is rising and the JN.1 sub-variant has been detected in the country, there is no cause of immediate concern as 92% of those infected are opting for home-based treatment, indicating a mild illness, officials had said.

There is also no increase in hospitalisation rates and COVID-19 is an incidental finding in those hospitalised due to other medical conditions, they had said.

In a letter to the states and Union territories last week, Union Health Secretary Sudhansh Pant underlined the critical COVID-19 control-and-management strategies considering the upcoming festive season and advised them to put in place the requisite public health measures to minimise the risk of increase in the transmission of the disease.

The states have been urged to ensure effective compliance of the detailed operational guidelines for a revised Covid surveillance strategy shared by the Union Ministry of Health and Family Welfare. The states have been asked to monitor and report district-wise cases of Influenza-like Illness (ILI) and Severe Acute Respiratory Illness (SARI) from all health facilities regularly for an early detection of a rising trend of cases.

The country’s Covid case tally is currently at 4,50,09,248 (4.50 crore). The number of people who have recuperated from the disease has risen to 4,44,71,860 (4.44 crore) while the national recovery rate stands at 98.81%, according to the health ministry website.

The case fatality rate stands at 1.19%. According to the ministry website, 220.67 crore Covid vaccine doses have been administered.

The JN.1 (BA.2.86.1.1) sub-variant of Covid emerged in August in Luxembourg. It is a descendant of the BA.2.86 lineage (Pirola) of SARS COV2.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

 Daily Newsletter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Previous Article

Oil Fluctuates as Traders Assess China’s Vow, Unrest in Libya

Next Article

Shanghai residents turn to NFTs to record COVID lockdown, combat censorship

LIVE TV

today's market

index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95

Currency

Company Price Chng %Chng
Dollar-Rupee 73.3500 0.0000 0.00
Euro-Rupee 89.0980 0.0100 0.01
Pound-Rupee 103.6360 -0.0750 -0.07
Rupee-100 Yen 0.6734 -0.0003 -0.05
Quiz
Powered by
Are you a Crypto Head? It’s time to prove it!
10 Questions · 5 Minutes
Start Quiz Now
Win WRX (WazirX token) worth Rs. 1500.
Question 1 of 5

What coins do you think will be valuable over next 3 years?

Answer Anonymously

Should Elon Musk be able to buy Twitter?

 5 Minutes Read

As COVID-19 cases rise, WHO asks countries to strengthen surveillance

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

 Listen to the Article (6 Minutes)

Summary

WHO has classified JN.1 as a variant of interest following its rapid global spread. In recent weeks, JN.1 was reported in multiple countries, and its prevalence has been rapidly increasing globally.

The World Health Organisation (WHO) has urged countries in South-East Asia to strengthen surveillance in view of the increasing cases of respiratory diseases, including due to COVID-19 and its new sub-variant JN.1, and influenza.

The WHO also urged people to take protective measures.

“The COVID-19 virus continues to evolve, change, and circulate in all countries globally. While current evidence suggests the additional public health risk posed by JN.1 is low, we must continue to track the evolution of these viruses to tailor our response.

“For this, countries must strengthen surveillance and sequencing, and ensure sharing of data,” said Dr Poonam Khetrapal Singh, regional director, WHO South-East Asia.

WHO has classified JN.1 as a variant of interest following its rapid global spread. In recent weeks, JN.1 was reported in multiple countries, and its prevalence has been rapidly increasing globally.

Considering the limited available evidence, the additional public health risk posed by JN.1 is currently evaluated as low at the global level, Singh said.

It is anticipated that this variant may cause an increase in COVID-19 cases amid surge of infections of other viral and bacterial infections, especially in countries entering the winter season.

“As people travel and gather for festivities during the holiday season, spending a lot of time together indoors where poor ventilation facilitates transmission of viruses that cause respiratory diseases, they must take protective measures and seek timely clinical care when unwell,” said Dr Khetrapal Singh.

The regional director also emphasised on the importance of vaccination against COVID-19 and influenza, especially for people at high risk.

“All WHO-approved COVID-19 vaccines continue to protect against severe diseases and deaths from all variants including JN.1,” she said.

In May, following sustained decline in the trajectory of COVID-19 cases, hospitalisations and deaths, and high levels of population immunity to SARS-CoV2, WHO declared that COVID-19 no longer constituted a public health emergency of international concern.

While considerable progress has been made in establishing and strengthening a global system to detect and rapidly assess risks posed by SARS-CoV2, testing and reporting of COVID-19 cases has decreased.

With COVID-19 continuing to circulate at high levels globally, countries must strengthen surveillance, sequencing, and reporting to effectively manage respiratory diseases and to protect people’s health, the regional director said.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

 Daily Newsletter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Previous Article

Oil Fluctuates as Traders Assess China’s Vow, Unrest in Libya

Next Article

Shanghai residents turn to NFTs to record COVID lockdown, combat censorship

LIVE TV

today's market

index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95

Currency

Company Price Chng %Chng
Dollar-Rupee 73.3500 0.0000 0.00
Euro-Rupee 89.0980 0.0100 0.01
Pound-Rupee 103.6360 -0.0750 -0.07
Rupee-100 Yen 0.6734 -0.0003 -0.05
Quiz
Powered by
Are you a Crypto Head? It’s time to prove it!
10 Questions · 5 Minutes
Start Quiz Now
Win WRX (WazirX token) worth Rs. 1500.
Question 1 of 5

What coins do you think will be valuable over next 3 years?

Answer Anonymously

Should Elon Musk be able to buy Twitter?

 5 Minutes Read

India logs 656 new COVID-19 cases, active case tally now 3,742

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

 Listen to the Article (6 Minutes)

Summary

India has reported 656 new COVID infections, bringing active cases to 3,742. The death toll reached 5,33,333, with one new fatality. The total cases stand at 45 million, with 44.47 million recoveries — a 98.81% recovery rate. The case fatality rate is 1.19%. The country has administered 2.2 billion vaccine doses.

India saw a single-day rise of 656 COVID infections while the active cases have increased to 3,742, according to Union health ministry data updated on Sunday.

The death toll was recorded at 5,33,333 with one new death reported from Kerala in 24 hours, the data updated at 8 am showed.

The country’s COVID case tally is 45 million (4,50,08,620).

The number of people who have recuperated from the disease has increased to 44.47 million and the national recovery rate stands at 98.81%, according to the health ministry’s website.

The case fatality rate stands at 1.19%.

According to the ministry’s website, 2.2 billion doses of COVID vaccines have been administered in the country so far.

Also read: New COVID-19 strain JN.1 mild, high vaccination rate eases concerns: Max Healthcare

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

 Daily Newsletter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Previous Article

Oil Fluctuates as Traders Assess China’s Vow, Unrest in Libya

Next Article

Shanghai residents turn to NFTs to record COVID lockdown, combat censorship

LIVE TV

today's market

index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95

Currency

Company Price Chng %Chng
Dollar-Rupee 73.3500 0.0000 0.00
Euro-Rupee 89.0980 0.0100 0.01
Pound-Rupee 103.6360 -0.0750 -0.07
Rupee-100 Yen 0.6734 -0.0003 -0.05
Quiz
Powered by
Are you a Crypto Head? It’s time to prove it!
10 Questions · 5 Minutes
Start Quiz Now
Win WRX (WazirX token) worth Rs. 1500.
Question 1 of 5

What coins do you think will be valuable over next 3 years?

Answer Anonymously

Should Elon Musk be able to buy Twitter?

 5 Minutes Read

COVID-19 cases on the rise in India — what we know so far

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

 Listen to the Article (6 Minutes)

Summary

The focus remains on the JN.1 COVID variant, which has infected 21 persons so far, as per NITI Aayog member (Health) Dr V.K. Paul. Nineteen cases are from Kerala and one each from Maharashtra and Kerala, as per news reports.

India recorded 614 new coronavirus infections in the past 24 hours. This is the highest number the country has reported since May 21 this year. 

The focus now remains on the JN.1 COVID variant, which has infected 21 persons so far, as per NITI Aayog member (Health) Dr V.K. Paul. According to media reports, 19 of the infected are from Kerala and one each from Maharashtra and Kerala. 

There has been a steep rise in active cases from 115 on December 6 to 614 on December 20. Over the past two weeks, 16 deaths related to COVID-19 were recorded. The last 24 hours have witnessed three deaths. 

As per the latest Health Ministry data, India now has 2,311 active cases with the overall death toll to date at 5.33 lakh and the COVID cases tally at 4.50 crore.

This comes after the World Health Organization (WHO) on Tuesday (December 19) classified JN.1 as a separate variant of interest (VOI). It was previously classified as VOI as part of BA.2.86 sublineages. The WHO defines a VOI as one that has genetic changes which could increase its transmissibility and ability to evade vaccines.

“Based on the available evidence, the additional global public health risk posed by JN.1 is currently evaluated as low,” WHO added.

JN.1 differs with an additional mutation in the spike protein. This variant has been found in many countries around the world, including in China and the United States.

Health experts are assuring the public to remain calm as the infection is mild and available treatments are effective. They’re calling for adherence to existing precautionary measures. As it happens with most respiratory viruses, including the influenza viruses, the circulating viruses continue their mutation.

 “However, the government’s steps should not be over-interpreted by citizens, and there is no reason to be worried. We humans live in a world inhabited by viruses, which are many folds higher than humans on this planet,” Chandrakant Lahariya, a senior consultant physician told PTI.

Paul highlighted that about 91-92% of those infected are opting for home-based treatment.

Health Minister Mansukh Mandaviya on Wednesday, December 20, reviewed the COVID-19 situation in India and the preparedness of public health systems in view of rising cases. “It is important to be on alert and be prepared against new and emerging strains of the coronavirus,” he said.

“No increase in hospitalisation rates has been witnessed due to COVID-19. The cases that have been hospitalised were due to other medical conditions and COVID was an incidental finding,” Union Health Secretary Sudhansh Pant said.

Also Read:Covid sub-variant JN.1 detected in 21 cases across three states: NITI Aayog Member V K Paul

 

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

 Daily Newsletter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Previous Article

Oil Fluctuates as Traders Assess China’s Vow, Unrest in Libya

Next Article

Shanghai residents turn to NFTs to record COVID lockdown, combat censorship

LIVE TV

today's market

index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95

Currency

Company Price Chng %Chng
Dollar-Rupee 73.3500 0.0000 0.00
Euro-Rupee 89.0980 0.0100 0.01
Pound-Rupee 103.6360 -0.0750 -0.07
Rupee-100 Yen 0.6734 -0.0003 -0.05
Quiz
Powered by
Are you a Crypto Head? It’s time to prove it!
10 Questions · 5 Minutes
Start Quiz Now
Win WRX (WazirX token) worth Rs. 1500.
Question 1 of 5

What coins do you think will be valuable over next 3 years?

Answer Anonymously

Should Elon Musk be able to buy Twitter?

 5 Minutes Read

Singapore sees COVID-19 surge, most cases due to JN.1 variant

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

 Listen to the Article (6 Minutes)

Summary

Based on the available international and local data, there is currently no clear indication that BA.2.86 or JN.1 are more transmissible or cause more severe disease than other circulating variants, Singapore Ministry of Health said in a media release.

COVID-19 has made a comeback. The Singapore Ministry of Health (MOH) Friday said the estimated number of cases from December 3 to 9 increased to 56,043, a 75% jump compared with 32,035 cases in the previous week.

The vast majority of cases are infected by the JN.1 variant, a sublineage of BA.2.86. The average daily COVID-19 hospitalisations rose from 225 to 350. The average daily cases in the intensive care unit rose from four to nine, Channel News Asia reported.

The MOH said it “strongly encourages” people to wear a face mask in crowded places even if they are not ill, especially indoors or when visiting vulnerable people.

“Based on the available international and local data, there is currently no clear indication that BA.2.86 or JN.1 are more transmissible or cause more severe disease than other circulating variants,” MOH said in a media release. Urging the public to exercise personal and social responsibility, the ministry said people who are unwell with acute respiratory infection symptoms should stay at home and avoid contact with others.

It added that those who are travelling should wear a mask at the airport, purchase travel insurance and avoid crowded areas with poor ventilation. “We urge the public to seek medical treatment at a hospital’s emergency department only for serious or life-threatening emergencies,” stressed the ministry.

“This will preserve our hospital capacity for patients who truly need acute hospital care and allow those with severe illness to receive timely treatment,” the channel had MOH as saying. The Health Ministry said it has been working with public hospitals for contingency planning, such as ensuring adequate manpower and deferring non-urgent elective surgeries to maximise bed capacity for urgent cases in need of acute care.

“In addition, hospitals are tapping on step-down facilities like Transitional Care Facilities and alternative care models like Mobile Inpatient Care@Home (MIC@Home) to ensure proper right-siting of patients,” MOH said. A second COVID-19 Treatment Facility will open this weekend at Singapore EXPO Hall 10, augmenting capacity at the existing facility at Crawfurd Hospital.

A treatment facility already operates at Crawfurd Hospital in Adam Road. Together, the two facilities can take more than 80 patients, and the new facility can be expanded, if necessary. In addition, hospitals will take steps to meet the rise in demand for beds.

“To preserve our healthcare capacity, MOH has been working with public hospitals for contingency planning, including ensuring adequate manpower and deferring of non-urgent electives to maximise bed capacity for urgent cases in need of acute care,” the ministry said. In the week that ended December 9, twenty-three COVID-19 patients were admitted to intensive care units (ICUs), up from nine the previous week, and the highest on a weekly basis for the year. A total of 763 patients were hospitalised with the virus.

MOH said travellers should take precautions such as wearing a mask at the airport, buying travel insurance in case they need medical care overseas and avoiding crowded areas with poor ventilation. Health Minister Ong Ye Kung said on December 13 that the healthcare impact of the latest spike in numbers is low, with fewer than 10 cases in ICUs at any one time.

Although more than 560 Covid patients were hospitalised on December 13, it is a fraction of the 1,726 at the peak of the pandemic. In the week of December 3 to 9, polyclinics saw 3,590 acute upper respiratory infections a day up from 2,970 a day the previous week. Polyclinics, which treat about 20 percent of acute illness cases in primary care, serve as a yardstick for the nation.

Doctors are urging people to get both the influenza vaccine and Covid-19 booster shots, especially if they are medically vulnerable or are seniors with underlying medical conditions, for whom such infections can be serious. The flu vaccine, which protects against the main strains now circulating here, is free for those who have signed up with Healthier SG, the national healthcare scheme to promote better health among Singaporeans.

Flu kills about 600 people a year here. In comparison, Covid-19 caused 226 deaths in the first 10 months of 2023, according to a report by The Straits Times.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

 Daily Newsletter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Previous Article

Oil Fluctuates as Traders Assess China’s Vow, Unrest in Libya

Next Article

Shanghai residents turn to NFTs to record COVID lockdown, combat censorship

LIVE TV

today's market

index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95

Currency

Company Price Chng %Chng
Dollar-Rupee 73.3500 0.0000 0.00
Euro-Rupee 89.0980 0.0100 0.01
Pound-Rupee 103.6360 -0.0750 -0.07
Rupee-100 Yen 0.6734 -0.0003 -0.05
Quiz
Powered by
Are you a Crypto Head? It’s time to prove it!
10 Questions · 5 Minutes
Start Quiz Now
Win WRX (WazirX token) worth Rs. 1500.
Question 1 of 5

What coins do you think will be valuable over next 3 years?

Answer Anonymously

Should Elon Musk be able to buy Twitter?